医学
阿片类药物使用障碍
慢性疼痛
类阿片
多学科方法
美沙酮
干预(咨询)
阿片类药物过量
重症监护医学
神经病理性疼痛
疼痛管理
加药
队列
物理疗法
阿片相关疾病
精神科
缓和医疗
美沙酮维持
止痛药
对乙酰氨基酚
丁丙诺啡
类阿片流行病
疼痛障碍
氢吗啡酮
应急管理
队列研究
梅德林
作者
Sarah Humphreys,Vani George,Tessa Gomez,Sanjana C. Koshy,Jessica Robinson‐Papp,Ashly E. Jordan,David C. Perlman
出处
期刊:Pain management
[Future Medicine]
日期:2026-06-16
卷期号:16 (9): 985-993
标识
DOI:10.1080/17581869.2026.2686786
摘要
BACKGROUND: Chronic non-cancer pain and opioid use disorder (OUD) are common co-morbidities. Clinical guidelines and regulatory changes have created challenges for providers and programs in which chronic pain and OUD treatment may be sub-optimally integrated for patients receiving long-term opioid therapy (LTOT). METHODS: We identified a cohort of 61 patients in HIV primary care who met criteria for LTOT (i.e. prescribed opioids for chronic non-cancer pain >90 days) and who experienced disruptions in pain management and present an analytic case study. A multidisciplinary team developed a two-step intervention to mitigate withdrawal and overdose risk and to facilitate ongoing safe, effective pain management. RESULTS: Among 61 patients, 29.5% were receiving methadone for pain and 9.8% were receiving LTOT for pain while enrolled in methadone OUD treatment programs. All 61 LTOT patients were referred for pain management reassessment. The following assessments were made: 24.6% had chronic pain without OUD; 9.8% had OUD and transitioned to OUD treatment; 3.3% self-elected to stop opioids; 29.5% were consensually initiated on a slow consensual opioid tapering schedule. CONCLUSIONS: A multidisciplinary intervention can provide overdose risk mitigation, facilitate pain and OUD re-assessments and can guide ongoing management of cohorts of patients previously maintained on LTOT for chronic non-cancer pain.
科研通智能强力驱动
Strongly Powered by AbleSci AI